Sickle cell disease (SCD) is characterized by intravascular hemolysis and inflammation coupled to a 400-fold greater incidence of invasive pneumococcal infection resulting in fulminant, lethal pneumococcal sepsis. Mechanistically, invasive infection is facilitated by a proinflammatory state that enhances receptor-mediated endocytosis of pneumococci into epithelial and endothelial cells. As statins reduce chronic inflammation, in addition to their serum cholesterol-lowering effects, we hypothesized that statin therapy might improve the outcome of pneumococcal infection in SCD. In this study, we tested this hypothesis in an experimental SCD mouse model and found that statin therapy prolonged survival following pneumococcal challenge. The protective effect resulted in part from decreased platelet-activating factor receptor expression on endothelia and epithelia, which led to reduced bacterial invasion. An additional protective effect resulted from inhibition of host cell lysis by pneumococcal cholesterol-dependent cytotoxins (CDCs), including pneumolysin. We conclude therefore that statins may be of prophylactic benefit against invasive pneumococcal disease in patients with SCD and, more broadly, in settings of bacterial pathogenesis driven by receptor-mediated endocytosis and the CDC class of toxins produced by Gram-positive invasive bacteria.
Jason W. Rosch, Angela R. Boyd, Ernesto Hinojosa, Tamara Pestina, Yunming Hu, Derek A. Persons, Carlos J. Orihuela, Elaine I. Tuomanen
Title and authors | Publication | Year |
---|---|---|
Cardiotoxicity during Invasive Pneumococcal Disease
AO Brown, ER Millett, JK Quint, CJ Orihuela |
American journal of respiratory and critical care medicine | 2015 |
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections
AÃ Rangel-Vega, LR Bernstein, EA Mandujano-Tinoco, SJ GarcÃa-Contreras, R GarcÃa-Contreras |
Frontiers in microbiology | 2015 |
Rethinking Risk for Pneumococcal Disease in Adults: The Role of Risk Stacking
SI Pelton, KM Shea, D Weycker, RA Farkouh, DR Strutton, J Edelsberg |
Open Forum Infectious Diseases | 2015 |
Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
R Rajamuthiah, BB Fuchs, AL Conery, W Kim, E Jayamani, B Kwon, FM Ausubel, E Mylonakis, PJ Planet |
PloS one | 2015 |
A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus
R Rajamuthiah, E Jayamani, AL Conery, BB Fuchs, W Kim, T Johnston, A Vilcinskas, FM Ausubel, E Mylonakis, S Bhattacharjya |
PloS one | 2015 |
Statin-Conferred Enhanced Cellular Resistance against Bacterial Pore-Forming Toxins in Airway Epithelial Cells
S Statt, JW Ruan, LY Hung, CY Chang, CT Huang, JH Lim, JD Li, R Wu, CY Kao |
American journal of respiratory cell and molecular biology | 2015 |
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice
EA Rahal, WN Constantin, N Zeidan, AM Abdelnoor |
Frontiers in microbiology | 2015 |